Ignite Creation Date:
2025-12-25 @ 2:32 AM
Ignite Modification Date:
2026-01-04 @ 6:38 PM
Study NCT ID:
NCT05332834
Status:
COMPLETED
Last Update Posted:
2024-09-27
First Post:
2022-03-31
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase 1 Study of Single and Multiple Intravenous Doses of SM17 in Healthy Subjects
Sponsor:
SinoMab BioScience Ltd
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
SM17-101
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None